Projects per year
Personal profile
External Positions
Member, American Society of Gene and Cell Therapy
2010 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Mingling life imaging and cell subpopulations expression analysis in NHP lungs targeted with exosomeassociated double AAV vectors
Aslanidi, G. (PI), Graham, M. L. (PI) & Zimmermann, J. (PI)
NIH NATIONAL INST OF ALLERGY & INFECT DI
6/25/25 → 5/31/27
Project: Research project
-
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma
Aslanidi, G. (PI) & Borgatti, A. M. (PI)
12/8/23 → 11/30/28
Project: Research project
-
Viral vector technology for cell type specific gene delivery
Aslanidi, G. (PI), Schmidt, D. (PI), Gordon, W. R. (CoI), LeBeau, A. (CoI) & McIvor, R. S. (Other Role)
NIH NIGMS NATL INST OF GENERAL
3/1/22 → 2/28/27
Project: Research project
-
Optimized Production and Validation of Rationally Designed AAV Vectors for Cockayne Syndrome Gene Therapy
Aslanidi, G. (PI), Pacak, C. A. (PI) & Kang, P. B. (CoI)
DHHS FOOD & DRUG ADMINISTRATION (FDA)
9/1/21 → 8/31/25
Project: Research project
-
Combating lung cancer resistance to EGFR targeted therapy
Aslanidi, G. (PI), Hoeppner, L. H. (PI) & Yang, R. (Other Role)
1/1/20 → 12/31/21
Project: Research project
-
A synthetic platform for developing recombinant adeno-associated virus type 8 producer cell lines
Lin, Y. C., Kuo, H. J., Lu, M., Mahl, T., Aslanidi, G. & Hu, W. S., May 1 2025, In: Biotechnology Progress. 41, 3, e70009.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Consecutive Affinity and Ion-Exchange Chromatography for AAV9 Vectors Purification
Duzenli, O. F. & Aslanidi, G., Feb 2025, In: Biomedicines. 13, 2, 361.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in mice
Chauhan, M., Daugherty, A. L., Khadir, F., Duzenli, O. F., Hoffman, A., Tinklenberg, J. A., Kang, P. B., Aslanidi, G. & Pacak, C. A., Dec 2024, In: Journal of Translational Medicine. 22, 1, 824.Research output: Contribution to journal › Article › peer-review
Open Access14 Link opens in a new tab Scopus citations -
Insights in AAV-mediated antigen-specific immunity and a strategy for AAV vaccine dose reduction through AAV-extracellular vesicle association
Molina, E., Tejero, M., Duzenli, O. F., Kuoch, H., Caine, C., Krotova, K., Paulaitis, M. & Aslanidi, G., Dec 12 2024, In: Molecular Therapy Methods and Clinical Development. 32, 4, 101358.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Bioengineered Hybrid Rep 2/6 Gene Improves Encapsulation of a Single-Stranded Expression Cassette into AAV6 Vectors
Tejero, M., Duzenli, O. F., Caine, C., Kuoch, H. & Aslanidi, G., Oct 2023, In: Genes. 14, 10, 1866.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations